Brief: Precision Biosciences Highlights Preclinical Data, Outlines Design Of First-In-Human Clinical Trial For PBGENE-HBV

Precision Biosciences

15/11/2024 12:06

Nov 15 (Reuters) - Precision BioSciences Inc  DTIL.O :
    * PRECISION BIOSCIENCES HIGHLIGHTS PRECLINICAL DATA AND
OUTLINES
DESIGN OF FIRST-IN-HUMAN CLINICAL TRIAL FOR PBGENE-HBV FOR
TREATMENT OF CHRONIC HEPATITIS B
    * PRECISION BIOSCIENCES INC - PBGENE-HBV DATA SUPPORT
ADVANCEMENT
INTO FIRST-IN-HUMAN STUDY
    * PRECISION BIOSCIENCES INC - PHASE 1 TRIAL ELIMINATE-B TO
ASSESS
SAFETY AND EFFICACY
    * PRECISION BIOSCIENCES INC - GLOBAL STUDY RECRUITING
PATIENTS,
U.S. IND EXPECTED IN 2025

Source text:  urn:newsml:reuters.com:*:nBw82YTNpa
Further company coverage:  DTIL.O 

 ((Reuters.Briefs@thomsonreuters.com;))